List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastrointestinal Stromal Tumor (GIST) Drug Overall Market Size
2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size: 2021 VS 2028
2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Gastrointestinal Stromal Tumor (GIST) Drug Players in Global Market
3.2 Top Global Gastrointestinal Stromal Tumor (GIST) Drug Companies Ranked by Revenue
3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Companies
3.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Companies
3.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Gastrointestinal Stromal Tumor (GIST) Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastrointestinal Stromal Tumor (GIST) Drug Players in Global Market
3.8.1 List of Global Tier 1 Gastrointestinal Stromal Tumor (GIST) Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastrointestinal Stromal Tumor (GIST) Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Markets, 2021 & 2028
4.1.2 Amcasertib
4.1.3 Anagrelide hydrochloride CR
4.1.4 APG-1351
4.1.5 Binimetinib
4.1.6 Others
4.2 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue & Forecasts
4.2.1 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2022
4.2.2 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2023-2028
4.2.3 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales & Forecasts
4.3.1 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2022
4.3.2 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2023-2028
4.3.3 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2017-2028
4.4 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2021 & 2028
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue & Forecasts
5.2.1 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2022
5.2.2 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2023-2028
5.2.3 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales & Forecasts
5.3.1 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2022
5.3.2 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2023-2028
5.3.3 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2017-2028
5.4 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2021 & 2028
6.2 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue & Forecasts
6.2.1 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2022
6.2.2 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2023-2028
6.2.3 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales & Forecasts
6.3.1 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2022
6.3.2 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2023-2028
6.3.3 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2028
6.4.2 By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2028
6.4.3 US Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.4.4 Canada Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.4.5 Mexico Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2028
6.5.2 By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2028
6.5.3 Germany Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.5.4 France Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.5.5 U.K. Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.5.6 Italy Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.5.7 Russia Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.5.8 Nordic Countries Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.5.9 Benelux Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2028
6.6.2 By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2028
6.6.3 China Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.6.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.6.5 South Korea Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.6.6 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.6.7 India Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2028
6.7.2 By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2028
6.7.3 Brazil Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.7.4 Argentina Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2017-2028
6.8.3 Turkey Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.8.4 Israel Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
6.8.6 UAE Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Ariad Pharmaceuticals, Inc.
7.1.1 Ariad Pharmaceuticals, Inc. Corporate Summary
7.1.2 Ariad Pharmaceuticals, Inc. Business Overview
7.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.1.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.1.5 Ariad Pharmaceuticals, Inc. Key News
7.2 Arog Pharmaceuticals, Inc.
7.2.1 Arog Pharmaceuticals, Inc. Corporate Summary
7.2.2 Arog Pharmaceuticals, Inc. Business Overview
7.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.2.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.2.5 Arog Pharmaceuticals, Inc. Key News
7.3 Array BioPharma Inc.
7.3.1 Array BioPharma Inc. Corporate Summary
7.3.2 Array BioPharma Inc. Business Overview
7.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.3.5 Array BioPharma Inc. Key News
7.4 Astex Pharmaceuticals, Inc.
7.4.1 Astex Pharmaceuticals, Inc. Corporate Summary
7.4.2 Astex Pharmaceuticals, Inc. Business Overview
7.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.4.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.4.5 Astex Pharmaceuticals, Inc. Key News
7.5 Blueprint Medicines Corporation
7.5.1 Blueprint Medicines Corporation Corporate Summary
7.5.2 Blueprint Medicines Corporation Business Overview
7.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.5.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.5.5 Blueprint Medicines Corporation Key News
7.6 Boston Biomedical, Inc.
7.6.1 Boston Biomedical, Inc. Corporate Summary
7.6.2 Boston Biomedical, Inc. Business Overview
7.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.6.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.6.5 Boston Biomedical, Inc. Key News
7.7 Calithera Biosciences, Inc.
7.7.1 Calithera Biosciences, Inc. Corporate Summary
7.7.2 Calithera Biosciences, Inc. Business Overview
7.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.7.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.7.5 Calithera Biosciences, Inc. Key News
7.8 Chipscreen Biosciences Ltd
7.8.1 Chipscreen Biosciences Ltd Corporate Summary
7.8.2 Chipscreen Biosciences Ltd Business Overview
7.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.8.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.8.5 Chipscreen Biosciences Ltd Key News
7.9 Deciphera Pharmaceuticals, LLC
7.9.1 Deciphera Pharmaceuticals, LLC Corporate Summary
7.9.2 Deciphera Pharmaceuticals, LLC Business Overview
7.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.9.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.9.5 Deciphera Pharmaceuticals, LLC Key News
7.10 F. Hoffmann-La Roche Ltd.
7.10.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.10.2 F. Hoffmann-La Roche Ltd. Business Overview
7.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.10.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.10.5 F. Hoffmann-La Roche Ltd. Key News
7.11 Horizon Pharma Plc
7.11.1 Horizon Pharma Plc Corporate Summary
7.11.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Business Overview
7.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.11.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.11.5 Horizon Pharma Plc Key News
7.12 Immunicum AB
7.12.1 Immunicum AB Corporate Summary
7.12.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Business Overview
7.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.12.4 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.12.5 Immunicum AB Key News
7.13 Jiangsu Hengrui Medicine Co., Ltd.
7.13.1 Jiangsu Hengrui Medicine Co., Ltd. Corporate Summary
7.13.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Business Overview
7.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.13.4 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.13.5 Jiangsu Hengrui Medicine Co., Ltd. Key News
7.14 Kolltan Pharmaceuticals, Inc.
7.14.1 Kolltan Pharmaceuticals, Inc. Corporate Summary
7.14.2 Kolltan Pharmaceuticals, Inc. Business Overview
7.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.14.4 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.14.5 Kolltan Pharmaceuticals, Inc. Key News
7.15 Natco Pharma Limited
7.15.1 Natco Pharma Limited Corporate Summary
7.15.2 Natco Pharma Limited Business Overview
7.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.15.4 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.15.5 Natco Pharma Limited Key News
7.16 Nerviano Medical Sciences S.r.l.
7.16.1 Nerviano Medical Sciences S.r.l. Corporate Summary
7.16.2 Nerviano Medical Sciences S.r.l. Business Overview
7.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.16.4 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.16.5 Nerviano Medical Sciences S.r.l. Key News
7.17 Novartis AG
7.17.1 Novartis AG Corporate Summary
7.17.2 Novartis AG Business Overview
7.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.17.4 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.17.5 Novartis AG Key News
7.18 Omeros Corporation
7.18.1 Omeros Corporation Corporate Summary
7.18.2 Omeros Corporation Business Overview
7.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.18.4 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2017-2022)
7.18.5 Omeros Corporation Key News
8 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Analysis
8.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, 2017-2028
8.2 Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastrointestinal Stromal Tumor (GIST) Drug Supply Chain Analysis
10.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Value Chain
10.2 Gastrointestinal Stromal Tumor (GIST) Drug Upstream Market
10.3 Gastrointestinal Stromal Tumor (GIST) Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
